Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: A double-blind, randomized, placebo-controlled trial

Clinical and Experimental Allergy

Volumn 33, Issue 8, 2003, Pages 1076-1082

  Varney, V A ^a,b   Tabbah, K ^a   Mavroleon, G ^a   Frew, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

House dust mite (HDM); Late phase reactions (LPR); Rhinitis; Specific immunotherapy (SIT)

Indexed keywords

ALUTARD; CODEINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVALUATION; FEMALE; HOUSE DUST; HUMAN; IMMUNOTHERAPY; MALE; PERENNIAL RHINITIS; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SKIN TEST;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DUST; FEMALE; HUMANS; MALE; MIDDLE AGED; MITES; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 0041620600     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01735.x     Document Type: Article

References (21)

1. Turner KJ. In: Lessof MH, Lee TH, Kemeny DM, eds. Epidemiology of atopic diseases. An International textbook. New York: John Wiley & Sons, 1987:337-5.
2. Sporik R, Holgate ST, Platts-Mills AE, Cogswell JJ. Exposure to house dust mite allergen (Der pl) and the development of asthma in childhood. N Engl J Med 1990; 323:502-7.
3. WHO/IUIS. The current status of allergen immunotherapy. Working Group Report. Allergy 1989; 44:369-79.
4. Malling HJ, Weeke B. Immunotherapy. Position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 1993; 48 (Suppl. 14):9-35.
5. Committee on Safety of Medicines.. Desensitising vaccines. BMJ 1986; 293:948.
6. Hunt KJ, Sobotka AK, Amodio FJ, Valentine MD, Benton MW, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 229:257-61.
7. Varney VA, Gaga M, Frew AJ, Aber VA, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe hay fever uncontrolled by anti-allergic drugs. BMJ 1991; 302:265-9.
8. Varney VA, Tabbah K, Edwards J, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind, placebo-controlled trial. Clin Exp Allergy 1997; 27:860-7.
9. Malling HJ. Proposed guidelines for quantitative skin prick test procedures to determine the biological activity of allergenic extracts using parallel line assay. Allergy 1987; 42:391-4.
10. + Version 3.0. Update manual. Chicago: SPSS Inc, 1988.
11. Pienkowski MM, Norman PS, Lichtenstein LM. Suppression of late-phase skin reactions by immunotherapy with ragweed extract. J Allergy Clin Immunol 1985; 76:729-34.
12. Heymann PW, Chapman MD, Aalberse RC, Fox JW, Platts-Mills TAE. Antigenic and structural analysis of Group II allergens from house dust mite (Dermatophagoides Spp). J Allergy Clin Immunol 1989; 83:1055-67.
13. Lofkvist T, Agrell B, Dreborg S, Svensson G. Effects of immunotherapy with a purified standardised allergen preparation of Der f in adults with perennial allergic rhinoconjunctivitis. Allergy 1994; 49:100-7.
14. Olsen OT, Larsen KR, Jacobsen L, Svendsen UG. A 1-year, placebo-controlled, double-blind house dust mite immunotherapy study in asthmatic adults. Allergy 1997; 52:853-9.
15. Pichler CE, Marquardsen A, Sparholt S et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy 1997; 52:274-83.
16. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardised, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91:709-22.
17. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 79:660-77.
18. Gonzalez de la Cuesta C, Feijoo R, Rico P. A prospective safety-monitoring study of immunotherapy in mite-allergy patients with mass-units-standardised extract. Allergy 1997; 52:580-3.
19. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardised Dermatophagoides Pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989; 83:797-802.
20. Mosbech H, Dirksen A, Dreborg S et al. Hyposensitisation in asthmatics with mPGE-modified and unmodified house dust mite extract: IV. Occurrence and prediction of side effects. Allergy 1990; 45:142-50.
21. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J Clin Invest 1993; 92:644-51.